Scientists are making rapid progress toward a long-awaited goal that could help to reshape cancer care: mRNA cancer vaccines with the potential to significantly boost the immune system’s ability to ...
6don MSN
AI’s finest hour: Tech executive uses ChatGPT to create cancer vaccine that saved his dog’s life
A tech executive utilized artificial intelligence and genomic analysis to develop a personalized experimental cancer vaccine ...
COVID vaccination during pregnancy protects infants from hospitalization during their first 6 months of life. Published in ...
Paul Conyngham claims he used AI tools like ChatGPT and AlphaFold to create custom mRNA vaccines that helped cure his dog’s cancer after traditional treatments failed to stop the tumour.
Australian techie Paul Conyngham used ChatGPT and AlphaFold to develop a personalised mRNA vaccine, reportedly shrinking his ...
"The vaccine pushed back about 75 percent of the cancer," the dog owner, tech entrepreneur Paul Conyngham, said.
Australian tech entrepreneur Paul Conyngham claims that he used AI tools such as ChatGPT and AlphaFold to cure his dog's ...
Gadget Review on MSN
Man uses ChatGPT to design cancer vaccine that saved his dog's life
So you fire up ChatGPT and design a personalized mRNA vaccine that shrinks the tumor by half.
When his beloved dog was given months to live, an Australian man harnessed the power of machine learning and mRNA technology ...
Platform combines proprietary AI sequence optimization, novel genetic parts, and lab validation in application-relevant cell models to improve expression and half-life, delivering top candidates in ...
Interesting Engineering on MSN
ChatGPT helps create groundbreaking cancer treatment after dog’s diagnosis
Eight-year-old dog Rosie, once abandoned in bushland, found a new lease on life when ...
StockStory.org on MSN
Therapeutics stocks Q4 teardown: Moderna (NASDAQ:MRNA) vs the rest
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Moderna (NASDAQ:MRNA) and the best and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results